Adipo Therapeutics shares results of studies on potential obesity treatment

Adipo Therapeutics LLC, a late-stage, preclinical biopharmaceutical company developing a potential treatment for obesity and related metabolic disorders, presented data from two studies at the annual meeting of The Obesity Society in San Antonio.

Emergent calls on new CEO Joe Papa to lead turnaround following pandemic stumbles

Joe Papa is known for putting himself in a pickle. He’s made a career out of turnaround attempts, most recently at embattled Valeant Pharmaceuticals. Next

February 22, 2024

Powerful Senate committee demands testimony from CEO of bankrupt Steward hospital chain

Federal lawmakers investigating the Steward Health Care bankruptcy moved on Thursday to compel testimony from chief executive Ralph de la Torre about his role in

July 25, 2024

This Biomarker Predicts Survival in Autoimmune Lung Disease

One major subgroup of patients with interstitial lung disease (ILD) arising from polymyositis/dermatomyositis (PM/DM) survived significantly longer when serum levels of interferon-λ3 were relatively low,

December 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.